MedPath

重庆迈川医药科技有限公司

Ownership
-
Established
2020-06-30
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

5

NMPA:5

Drug Approvals

Polyethylene Glycol(3350)and Electrolytes Oral Solution

Product Name
复方聚乙二醇(3350)电解质口服溶液
Approval Number
国药准字H20253653
Approval Date
Mar 18, 2025
NMPA

Lactulose Oral Solution

Product Name
乳果糖口服溶液
Approval Number
国药准字H20249795
Approval Date
Dec 25, 2024
NMPA

Lactulose Oral Solution

Product Name
乳果糖口服溶液
Approval Number
国药准字H20249796
Approval Date
Dec 25, 2024
NMPA

Polyethylene Glycol(3350)and Electrolytes Powder

Product Name
复方聚乙二醇(3350)电解质散
Approval Number
国药准字H20249440
Approval Date
Nov 22, 2024
NMPA

Polyethylene Glycol Electrolytes Powder(Ⅲ)

Product Name
复方聚乙二醇电解质散(Ⅲ)
Approval Number
国药准字H20244801
Approval Date
Sep 3, 2024
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.